ATNF - 180 Life Sciences Corp. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ATNF (1690080)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
8 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2023-12-15
ATNFFeldmann MarcDirS - Sale$0.19-25,000115,497-18%-$4,700
2023-12-15
ATNFWoody James N.CEOP - Purchase$0.19+25,00066,888+60%+$4,700
2023-06-01
ATNFSteinman LawrenceDirP - Purchase$1.23+18,00048,129+60%+$22,068
2023-05-31
ATNFMcGovern Jr. Donald A.DirP - Purchase$1.15+10,00030,099+50%+$11,470
M
2023-05-18
ATNFMcGovern Jr. Donald A.DirP - Purchase$1.09+15,00020,099+294%+$16,300
2023-05-18
ATNFMarrone Pamela GDirP - Purchase$1.06+7,08212,469+131%+$7,507
2023-05-18
ATNFPamir OzanCFOP - Purchase$1.01+5,1628,983+135%+$5,214
2023-05-18
ATNFWoody James N.CEOP - Purchase$1.03+40,00041,888>999%+$41,200

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top